Guest guest Posted September 11, 2008 Report Share Posted September 11, 2008 Pharmaceutical Business Review 9th September 2008 FDA lists drugs under safety probes The FDA has announced its first quarterly report that lists certain drugs that are being evaluated for potential safety issues. The drugs have been identified based on a review of reports in FDA's Adverse Event Reporting System. The appearance of a drug on this list does not mean that the FDA has concluded that the drug has the listed risk, or that FDA has identified a causal relationship between the drug and the listed risk. It is on the list only because the FDA has identified a potential safety issue. Biogen Idec and Elan's multiple-sclerosis treatment Tysabri, Purdue Pharma's painkiller Oxycontin, Eli Lilly & Co's antidepressant Cymbalta are some of the drugs included in the FDA's quarterly list (January 2008 to March 2008). ************************************************************* Read the rest of the article here: http://www.pharmaceutical-business-review.com/article_news.asp?guid=038F8C86-E38\ 8-46A7-B3C9-275654670696 -- Not an MD Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.